Wikiera B, Jakubiak A, Łaczmanska I, Noczyńska A, Śmigiel R. Complex glycerol kinase deficiency – long-term follow-up of two patients. Pediatric Endocrinology Diabetes and Metabolism. 2021;27(3):227-231. doi:10.5114/pedm.2021.109681.
APA
Wikiera, B., Jakubiak, A., Łaczmanska, I., Noczyńska, A., & Śmigiel, R. (2021). Complex glycerol kinase deficiency – long-term follow-up of two patients. Pediatric Endocrinology Diabetes and Metabolism, 27(3), 227-231. https://doi.org/10.5114/pedm.2021.109681
Chicago
Wikiera, Beata, Aleksandra Jakubiak, Izabela Łaczmanska, Anna Noczyńska, and Robert Śmigiel. 2021. "Complex glycerol kinase deficiency – long-term follow-up of two patients". Pediatric Endocrinology Diabetes and Metabolism 27 (3): 227-231. doi:10.5114/pedm.2021.109681.
Harvard
Wikiera, B., Jakubiak, A., Łaczmanska, I., Noczyńska, A., and Śmigiel, R. (2021). Complex glycerol kinase deficiency – long-term follow-up of two patients. Pediatric Endocrinology Diabetes and Metabolism, 27(3), pp.227-231. https://doi.org/10.5114/pedm.2021.109681
MLA
Wikiera, Beata et al. "Complex glycerol kinase deficiency – long-term follow-up of two patients." Pediatric Endocrinology Diabetes and Metabolism, vol. 27, no. 3, 2021, pp. 227-231. doi:10.5114/pedm.2021.109681.
Vancouver
Wikiera B, Jakubiak A, Łaczmanska I, Noczyńska A, Śmigiel R. Complex glycerol kinase deficiency – long-term follow-up of two patients. Pediatric Endocrinology Diabetes and Metabolism. 2021;27(3):227-231. doi:10.5114/pedm.2021.109681.
Complex glycerol kinase deficiency (CGKD) is a rare genetic syndrome which belongs to the group of contiguous gene syndromes and is caused by microdeletion of genes located in Xp21. Patients with CGKD present with features characteristic for adrenal hypoplasia, glycerol kinase deficiency, Duchenne muscular dystrophy and sometimes intellectual disability. We present a long-term follow-up of two unrelated boys with molecular diagnosis of complex glycerol kinase deficiency. Genetic examinations in both patients revealed a deletion on Xp21 chromosome including complete deletion of NR0B1 and GK genes. Additionally in patient 2 IL1RAPL1 genes were deleted. In separate MLPA test DMD gene deletion was diagnosed in both patients as follow: in patient 1 whole gene while in patient 2 the C-terminal region of DMD was deleted. Although the first symptom in both was salt loss syndrome, the course of the disease was different for them. We share our experience resulting from the opportunity of caring for patients with this rare disease from the beginning of their life to the end of pediatric care.